id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0610-0013,FDA,FDA-2008-D-0610,"Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an 
Influenza Pandemic",Notice,60 Day Proposed Information Collection,2017-10-31T04:00:00Z,2017,10,2017-10-31T04:00:00Z,2018-01-03T04:59:59Z,2017-11-01T01:03:17Z,2017-23659,0,0,0900006482c28640